Updated Monday, 8/10 After an active July, the US IPO market is taking a breather. Three companies are scheduled to raise $2.5 billion in the week ahead, led by Chinese real estate giant KE Holdings (BEKE). KE Holdings (BEKE), China's largest...read more
Houlihan Lokey, a leading mid-cap focused independent investment bank, raised $221 million by offering 10.5 million shares at $21, below the range of $22 to $24. Selling shareholders floated the entire IPO. Houlihan had originally planned to raise $300...read more
It's the final push for US IPOs before a four-week lull that should end in mid-September. Five IPOs are on the calendar this week, plus two blank check companies. Sickle cell biotech Global Blood Therapeutics could attract investor attention, while...read more
US IPO Week Ahead: The IPO market takes a breather in a 4 IPO week
Updated Monday, 8/10 After an active July, the US IPO market is taking a breather. Three companies are scheduled to raise $2.5 billion in the week ahead, led by Chinese real estate giant KE Holdings (BEKE). KE Holdings (BEKE), China's largest...read more
US IPO Weekly Recap: Sickle cell biotech pops 100% and investment bank goes public
nine IPOs...read more
Investment bank Houlihan Lokey prices downsized IPO below the range at $21
Houlihan Lokey, a leading mid-cap focused independent investment bank, raised $221 million by offering 10.5 million shares at $21, below the range of $22 to $24. Selling shareholders floated the entire IPO. Houlihan had originally planned to raise $300...read more
Week ahead: 5 IPOs set to price during the week of August 10
It's the final push for US IPOs before a four-week lull that should end in mid-September. Five IPOs are on the calendar this week, plus two blank check companies. Sickle cell biotech Global Blood Therapeutics could attract investor attention, while...read more